{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:11:52Z","timestamp":1787015512301,"version":"build-2736575974"},"reference-count":35,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The management of chronic alopecia areata (CAA) is challenging. There is currently no therapy that produces consistent successful hair regrowth. Systemic therapies, including prednisolone and steroid\u2010sparing agents (SSA), are often tried in patients with CAA. As there are no head\u2010to\u2010head clinical trials that compare efficacy of one SSA over another, retrospective studies of treatment in clinical practice may help guide clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the utility of SSAs in the treatment of AA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An electronic medical records search identified patients with AA and those prescribed azathioprine, cyclosporine or methotrexate between 2002 and 2019. Type of AA, treatment duration, reason for cessation, use of concurrent prednisolone, dose of prednisolone and duration of prednisolone use were recorded. The primary outcome was SSA continuation rate at 6 and 12\u00a0months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 852 AA patients were identified, among whom 138 patients had been treated with azathioprine, methotrexate or cyclosporine. Of these 138 patients treated with a SSA, 92 (66.7%) continued treatment for at least 12\u00a0months: 75.3% (55\/73) of azathioprine users, 50% (11\/22) of methotrexate users and 60.5% (26\/43) of cyclosporine users. At 12\u00a0months, 67.3% of azathioprine users required concurrent prednisolone at a mean dose of 5.6\u00a0mg daily, 63.6% of methotrexate users required prednisolone at a mean dose of 5\u00a0mg daily and 57.7% of cyclosporine users required prednisolone at a mean dose of 8.7\u00a0mg daily. The SSA was ceased due to an adverse event in 15.9% of patients and a lack of efficacy in 17.4%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The most well\u2010utilized SSA for CAA patients at our clinic was azathioprine. This study highlights that most CAA patients who commence treatment with azathioprine, methotrexate or cyclosporine continue that treatment for at least 12\u00a0months and most require concurrent low\u2010dose prednisolone to maintain remission or promote continued hair regrowth.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdv.16858","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T21:49:38Z","timestamp":1597096178000},"page":"2606-2612","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Utility of azathioprine, methotrexate and cyclosporine as steroid\u2010sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients"],"prefix":"10.1111","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-9864","authenticated-orcid":false,"given":"V.W.Y.","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Medicine Alfred Hospital Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sinclair","sequence":"additional","affiliation":[{"name":"Sinclair Dermatology East Melbourne Vic. Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,9]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.032"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1654068"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12941"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/jidsymp.2013.14"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10955.x"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.10.873"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12913"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.04.053"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2014.910312"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S131668"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-011-0569-6"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0276-3"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04576.x"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2015.12.055"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2013.839997"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1159\/000018184"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70032-D"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2016.28.5.569"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000247481"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10383.x"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20142869"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.09.010"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03700.x"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.45103"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01945.x"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.119671"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/jidsymp.2013.23"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2008.20.4.172"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70342-6"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1992.tb02706.x"},{"key":"e_1_2_5_32_1","first-page":"90","article-title":"The effect of methylprednisolone pulse\u2010therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis","volume":"11","author":"Shaheedi\u2010Dadras M","year":"2008","journal-title":"Arch Iran Med"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1159\/000441250"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1341608"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1159\/000339341"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.10.980"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.16858","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.16858","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.16858","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.16858","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T15:46:59Z","timestamp":1693756019000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.16858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/jdv.16858"],"URL":"https:\/\/doi.org\/10.1111\/jdv.16858","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"2020-02-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}